These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24100077)

  • 21. Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.
    Sukalovic V; Ignjatovic D; Tovilovic G; Andric D; Shakib K; Kostic-Rajacic S; Soskic V
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3967-72. PubMed ID: 22607670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A
    Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.
    Leopoldo M; Lacivita E; De Giorgio P; Fracasso C; Guzzetti S; Caccia S; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2008 Sep; 51(18):5813-22. PubMed ID: 18800769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
    J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists.
    Liu KG; Robichaud AJ; Bernotas RC; Yan Y; Lo JR; Zhang MY; Hughes ZA; Huselton C; Zhang GM; Zhang JY; Kowal DM; Smith DL; Schechter LE; Comery TA
    J Med Chem; 2010 Nov; 53(21):7639-46. PubMed ID: 20932009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]-ethyl]pyrid-2(1H)-ones with diversified 5-HT1A receptor activity.
    Paluchowska MH; Bugno R; Charakchieva-Minol S; Wesołowska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 2002; 54(6):641-6. PubMed ID: 12866719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
    Jean M; Renault J; Levoin N; Danvy D; Calmels T; Berrebi-Bertrand I; Robert P; Schwartz JC; Lecomte JM; Uriac P; Capet M
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5376-9. PubMed ID: 20708933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
    Modica MN; Intagliata S; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1427-30. PubMed ID: 25759032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
    Paluchowska MH; Kłodzińska A; Tatarczyńska E; Szaro A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):341-7. PubMed ID: 10091719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, radiolabeling and in vivo evaluation of [(11)C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT(7) receptor.
    Hansen HD; Lacivita E; Di Pilato P; Herth MM; Lehel S; Ettrup A; Andersen VL; Dyssegaard A; De Giorgio P; Perrone R; Berardi F; Colabufo NA; Niso M; Knudsen GM; Leopoldo M
    Eur J Med Chem; 2014 May; 79():152-63. PubMed ID: 24732791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
    Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A
    Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M
    Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In the search for a lead structure among series of potent and selective hydantoin 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Sobiło A; Olejarz A; Kucwaj-Brysz K; Satała G; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Chem Biol Drug Des; 2017 Dec; 90(6):1295-1306. PubMed ID: 28886235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.
    Zajdel P; Marciniec K; Maślankiewicz A; Paluchowska MH; Satała G; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Duszyńska B; Bojarski AJ; Pawłowski M
    Bioorg Med Chem; 2011 Nov; 19(22):6750-9. PubMed ID: 22001327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
    J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New arylpiperazines with flexible versus partly constrained linker as serotonin 5-HT(1A)/5-HT(7) receptor ligands.
    Kowalski P; Mitka K; Jaśkowska J; Duszyńska B; Bojarski AJ
    Arch Pharm (Weinheim); 2013 May; 346(5):339-48. PubMed ID: 23609855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.